Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series
Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series have?
Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series has 24 citations in the OpenAlex counts ScholarIQ stores.
When was Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series published?
Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series has 2021 year in the ScholarIQ index.
What is the open-access status of Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series?
Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series has gold oa status in the ScholarIQ index.
What is the DOI of Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series?
The DOI for Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series is on the source record.
What is the PMID of Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series?
The PMID for Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series is on the source record.
What is the OpenAlex record for Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series?
The OpenAlex for Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series is on the source record.